{"SPADE_N_03132": {"basic": {"SPADE ID": "SPADE_N_03132", "Peptide Name": "LL-37(17-29) (C-terminal fragment of LL-37, LL; Human, mammals, animals)", "Sequence": "FKRIVQRIKDFLR", "Source": "Homo sapiens", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Anticancer"], "Target Organism": "[Ref.16637646] Gram-negative bacterium:Escherichia coli K12(MIC=40 μM);Drug-resistant KBv cancer cells (LC50=60 μM), Drug-sensitive KB cancer cells (LC50=57 μM).[Ref.28178190]Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=16 μM), S. faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=16 μM), Salmonella typhimurium ATCC 14028 (MIC=32 μM), Salmonella typhimurium ATCC 7731 (MIC=16 μM). [Ref.23894079] Gram-positive bacteria :Staphylococcus aureus (ATCC 29213)(MIC=40 μM);Gram-negative bacteria :Escherichia coli (ATCC 25922)(MIC=5 μM)", "Linear/Cyclic": "Not included yet", "Sequence Length": 13}, "extended_data_url": "SPADE_N_03132_extended.json"}}